Tomas J. Philipson is a Swedish-born American economist who served as the Acting Chairman of the Council of Economic Advisers in the Trump administration.

"[8][2] Philipson asserted that public health threats do not usually cause harm to the economy and that the coronavirus would not be as bad as a normal flu season, although a September 2019 study by White House economists projected that a pandemic disease could kill hundreds of thousands of Americans and cause trillions of dollars in damage to the nation's economy.

PHE served a multitude of global Fortune 500 healthcare clients on a range of commercial and policy issues around the world.

Philipson is currently an advising board member and investor in several health care and medical companies which leverage modern technology such as Artificial Intelligence (AI).

These companies include iRemedy, Epigenetix, Biologx, Nested Knowledge, MEDA Angels, and GATC Health.

iRemedy is a technology-driven healthcare and medical products distributor geared towards government agencies, care providers, and consumers.

Epigenetix researches epigenetic drugs at the preclinical and clinical level for the precision targeting of lethal cancers while BiologX makes life-saving insulin affordable to more people around the world.